Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma

ConclusionWhile the use of immunotherapy for metastatic melanoma has increased over time, adoption varies widely across hospitals. Underinsured patients were more likely to receive treatment at low immunotherapy prescribing hospitals. The variation suggests inequity in access to these potentially life-saving drugs.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research